Search Site

Guarionex Joel DeCastro, MD, MPH

  • Assistant Professor of Urology at CUMC

This provider accepts new patients

Appointment Phone Number: (212) 305-0114

Guarionex Joel DeCastro, MD, MPH

G. Joel DeCastro, MD, MPH, an Assistant Professor of Urology at Columbia University Medical Center. Dr. DeCastro graduated with cum laude honors in Biology from Harvard University in 1997. He then went on to complete his medical school training, a Masters in Public Health, and his Urology residency at Columbia University Medical Center in New York. After residency, he completed a two-year fellowship in Urologic Oncology at the University of Chicago, focused on laparoscopic and robotic surgery. He serves on the review panel of numerous publications, including the Journal of Urology and the Journal of Endourology. He has authored multiple original research articles, book chapters, and editorials on urologic oncology. His present research is primarily on outcomes following treatment for bladder cancer.

Dr. DeCastro is an established expert in both robotic and laparoscopic techniques for treatment of urologic tumors, specifically for bladder, kidney, prostate, and testicular cancer. He sees patients both at the Allen Hospital and at the Herbert Irving Pavillion on the main hospital campus, and participates in most insurance plans.

Board Certifications

  • Urology

Areas of Expertise

  • Urologic Oncology
  • Testicular Cancer
  • Prostate Cancer
  • Kidney & Adrenal Cancer
  • Cancer Care
  • Bladder Cancer
  • Kidney Cancer
  • Laparoscopic Nephrectomy
  • Robotic Prostatectomy
  • Urologic Cancer

Languages Spoken

  • French
  • Spanish

Education & Training

  • MD, Columbia University College of Physicians and Surgeons
  • MPH, Columbia University Mailman School of Public Health
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: The University of Chicago Medical Center

Locations

  • Allen Hospital

    5141 Broadway
    New York, NY 10034
    For new and current patient appointments, call:
    (212) 305-0114
    Fax:
    (212) 932-4448
  • Herbert Irving Pavilion

    161 Fort Washington Avenue
    Floor: 11
    New York, NY 10032
    For new and current patient appointments, call:
    (212) 305-0114
    Fax:
    (212) 305-0129

NIH Grants

  • MULTI-INSTITUTIONAL STUDY TO EVALUATE DNA METHYLATION MARKERS FOR DETECTION OF PRIMARY BLADDER CANCERS IN URINE SAMPLES FROM A COHORT OF PATIENTS WITH HEMATURIA (P&S Industry Clinical Trial)

    May 22 2017 - May 22 2022

    A PHASE 1B, MULTICENTER, OPEN LABEL STUDY EVALUATING SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF GEMRIS 225 MG IN SUBJECTS WITH MUSCLE-INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER (P&S Industry Clinical Trial)

    Apr 27 2017 - Apr 27 2022

    INVESTIGATION OF A NONPARTICLE ALBUMIN-BOUND MTOR INHIBITOR, NABRAPAMYCIN, FOR THE INTRAVESICAL TREATMENT OF BCG RECURRENT OR REFRACTORY NON-MUSCLE INVASIVE TRANSITIONAL CELL BLADDER CANCER (Federal Gov)

    Apr 1 2013 - Dec 31 2017

    EFFICACY OF NAB-REPAMYCIN I THE TREATMENT OF BCG REFRACTORY OR RECURRENT MPM-MUSCLE (Private)

    Jul 1 2015 - Aug 31 2016